# Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction

> **NCT03033537** · — · COMPLETED · sponsor: **Adam International Hospital** · enrollment: 20 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Verapamil

## Key facts

- **NCT ID:** NCT03033537
- **Lead sponsor:** Adam International Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-01
- **Primary completion:** 2016-01-01
- **Final completion:** 2016-01-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033537, "Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03033537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*